Applications of Tiamulin in Industrial Manufacturing

Tiamulin serves as a critical active ingredient in modern veterinary pharmaceutical manufacturing, providing targeted, reliable anti-infective properties for animal health products. Our expertise in high-purity synthesis and stringent quality controls ensures safe integration into a variety of dosage forms for the livestock and poultry industries, while meeting demanding global standards.

1. Medicated Feed Additives for Swine Respiratory Disease Control

Tiamulin is widely incorporated into swine feed to address respiratory infections such as enzootic pneumonia and swine dysentery. Veterinary feed manufacturers depend on its proven effectiveness against Mycoplasma hyopneumoniae and Brachyspira hyodysenteriae, formulating pelleted or mash feeds that are distributed globally for use during grower and finisher stages. We supply granulated and microencapsulated grades to enable precisely dosed, homogeneous blending in commercial feed mills, supporting both routine prevention and outbreak interventions for modern intensive farming operations.

Industry compliance standards

• EU Regulation (EC) No 1831/2003 on additives for use in animal nutrition
• China Feed Additive Standards (GB/T 1886.127-2016)
• US FDA Title 21 CFR Part 558.274
• Good Manufacturing Practice (GMP) for veterinary drugs (China, EU, USA)

Typical usage ratio

• 30–100 mg/kg feed, adjusted according to veterinary prescription, disease pressure, and local regulatory maximum residue limits (MRLs)

Downstream process integration

• Direct addition into vitamin/mineral premixes or micro-ingredient batches; further mixed and homogenized during standard hydration and pelleting operations

Final product types

• Commercial medicated compound feeds for swine
• Pre-starter and starter feeds targeting young piglets
• Tiamulin premix products (for further mix-in at farm or regional feed plants)

2. Poultry Drinking Water Solutions and Soluble Powders

Animal pharmaceutical companies use Tiamulin to develop soluble formulations for fast administration via poultry drinking water systems, mainly for the control of chronic respiratory disease (CRD) and infectious synovitis in broilers, breeders, and layers. High-purity powder grades formulated for rapid dissolution avoid clogging in automated water lines, supporting mass-medication protocols. Producers emphasize particle fineness and flowability to minimize settling and ensure reliable dosimetry during acute infection outbreaks or routine programs in large-scale poultry operations.

Industry compliance standards

• European Pharmacopoeia (Ph. Eur.) and Chinese Veterinary Pharmacopoeia monographs for Tiamulin
• VICH GL9 (GCP for Veterinary field trials)
• US FDA Center for Veterinary Medicine cGMP requirements
• FAO/WHO Codex Alimentarius for veterinary drug residues in food products

Typical usage ratio

• 25–50 mg/L drinking water for 3–5 days, tailored by bodyweight, severity of infection, and withdrawal period requirements

Downstream process integration

• Mixing into sugar-based or mineral-supported carriers; packaged as soluble powders or liquid concentrates; reconstituted by poultry producers on site for direct use in automated watering systems

Final product types

• Soluble powder veterinary drugs for poultry drinking water
• Liquid oral solutions for poultry
• Feed supplement packages for disease management

3. Injectable Veterinary Formulations for Porcine and Avian Mycoplasmosis

Pharmaceutical manufacturing facilities use Tiamulin as the core active in sterile injectable suspensions for precise parenteral administration to pigs or poultry during acute phases of mycoplasmosis or other susceptible bacterial infections. These formulations demand stringent in-process controls from raw material dissolution, sterile filtration, and aseptic filling to ensure product safety and accurate dosing. Controlled-release or oil-based suspensions also feature where prolonged activity is required on farm. Our material supports consistent batch-to-batch reproducibility for both small and large-volume parenteral products.

Industry compliance standards

• EU GMP for manufacture of veterinary medicinal products (EudraLex Vol. 4)
• United States Pharmacopeia (USP) for sterile injectables
• National Veterinary Drug Standards (China) for injection formulations
• OECD Series on Good Laboratory Practice (GLP) for residue studies

Typical usage ratio

• 5–10 mg/kg body weight per injection; exact dose determined by diagnosis and animal size, following veterinary prescription

Downstream process integration

• Dissolution in aqueous, oil-based, or co-solvent media; sterile filtration; aseptic filling into glass or polymer ampoules/vials; secondary packaging with clear labeling on dose per mL

Final product types

• Ready-to-use Tiamulin injectable solutions or suspensions for pigs and poultry
• Veterinary single-dose and multi-dose vials
• Combination therapy injectables (with other antimicrobial agents, if approved)

4. Specialized Oral Drench and Paste Preparations for Small-Scale Livestock

Veterinary product manufacturers formulate Tiamulin into oral drenches and pastes for easy administration to pigs, poultry, and rabbits on small and medium-sized farms. This application relies on rapid absorption through the gastrointestinal tract, and producers blend the active into palatable, non-irritating carriers that mask potential taste aversion for young or stressed animals. Output consistency and product stability guide formulation strategies, and our controlled particle sizing and purity support safe compounding of accurate, user-friendly doses with defined expiration periods.

Industry compliance standards

• Australian PICS (Pharmaceutical Inspection Cooperation Scheme) GMP for veterinary medicines
• Pharmacopoeial standards of relevant jurisdiction (e.g., British Veterinary Pharmacopoeia, Chinese Veterinary Codex)
• Country-specific maximum residue limits (MRLs) for oral products in food animals
• ISO 9001:2015 for Quality Management Systems in veterinary preparations

Typical usage ratio

• 2–5 mg/kg body weight, single or repeated administration according to product label and species requirements

Downstream process integration

• Active content blended with aqueous, syrup, or suspension media; homogenized with viscosity modifiers as needed; dosed into calibrated syringes, bottles, or unit-dose packaging under cGMP protocols

Final product types

• Oral drench solutions for piglets and ducklings
• Medicated pastes for individual animal treatment
• Oral syringes for targeted use in small mammals